<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01122043</url>
  </required_header>
  <id_info>
    <org_study_id>R664/14/2009</org_study_id>
    <secondary_id>Other grant</secondary_id>
    <nct_id>NCT01122043</nct_id>
  </id_info>
  <brief_title>The SNEC DSAEK EndoGlide Clinical Trial</brief_title>
  <official_title>The SNEC DSAEK EndoGlide Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore Eye Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UK Network Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Singapore Eye Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the clinical safety and efficacy of the EndoGlide&#xD;
      as a donor insertion device in DSAEK surgery. The investigators hypotheses is that the&#xD;
      Endoglide will cause less endothelial damage compared to the investigators previous technique&#xD;
      of glide insertion but will have the same low complication rate as the previous device. Hence&#xD;
      the investigators aim to evaluate the surgical efficacy of the EndoGlide to enable consistent&#xD;
      double coiling of the donor lenticule in DSAEK surgery with minimal endothelial touch.&#xD;
      Evaluate ease of insertion of the EndoGlide through a 4 to 4.5mm scleral tunnel wound.&#xD;
      Evaluate ability of the EndoGlide to consistently effect complete wound sealing, so as to&#xD;
      stabilize anterior chamber with an AC maintainer in position. Evaluate ease of donor&#xD;
      pull-through from the EndoGlide chamber into the AC and to evaluate spontaneous uncoiling of&#xD;
      the donor in the AC. Evaluate clinical efficacy and safety outcomes in EndoGlide assisted&#xD;
      DSAEK surgery in study patients with corneal decompensation requiring DSAEK surgery, in terms&#xD;
      of postoperative visual acuity, primary graft failure rate, donor dislocation rate,&#xD;
      endothelial cell loss, and deturgescence of the host cornea and donor lenticule as measured&#xD;
      by corneal thickness parameters with the Visante AS-OCT. The investigators will perfprm a&#xD;
      prospective Phase II clinical trial using the EndoGlide for donor insertion in 100 corneal&#xD;
      patients referred to the SNEC Corneal Clinics of the study investigators with moderate&#xD;
      degrees of corneal decompensation from a variety of disorders which require DSAEK corneal&#xD;
      transplantation surgery, with or without concurrent cataract surgery, to restore visual&#xD;
      acuity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Graft Failure</measure>
    <time_frame>One month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Donor Graft Dislocation</measure>
    <time_frame>One week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial Cell loss</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Bullous Keratopathy</condition>
  <arm_group>
    <arm_group_label>Endoglide</arm_group_label>
    <description>Patients with moderate degrees of corneal decompensation from a variety of disorders which require DSAEK corneal transplantation surgery, with or without concurrent cataract surgery, to restore visual acuity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endoglide</intervention_name>
    <description>Device</description>
    <arm_group_label>Endoglide</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Bullous Keratopathy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. patients presenting with corneal decompensation or bullous keratopathy requiring&#xD;
             corneal transplantation for visual restoration and pain relief&#xD;
&#xD;
          2. Clinical diagnoses including post-surgical forms of corneal decompensation (all forms&#xD;
             of pseudophakic and aphakic bullous keratopathy including TASS and irreversible&#xD;
             Descemets detachment), post-laser corneal decompensation, Fuchs' and other forms of&#xD;
             endothelial dystrophy, traumatic corneal decompensation, post-inflammatory corneal&#xD;
             decompensation, etc.&#xD;
&#xD;
          3. Mild to moderate forms of corneal decompensation&#xD;
&#xD;
          4. patients who agree to study participation following full informed consent&#xD;
&#xD;
          5. patients who agree to adhere to the standard SNEC clinical DSAEK protocol in terms of&#xD;
             pre and postoperative investigations and follow-up visits up to 12 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Severe forms or late stage presentation of corneal decompensation with severe corneal&#xD;
             stromal scarring, unsuitable for DSAEK surgery as apposed to penetrating keratoplasty&#xD;
&#xD;
          2. patients with complex anterior segment complications precluding a successful DSAEK&#xD;
             procedure&#xD;
&#xD;
          3. patients unkeen to participate in the clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald Tan, MD FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore National Eye Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Singapore National Eye Centre</name>
      <address>
        <city>Singapore</city>
        <zip>168751</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>May 10, 2010</study_first_submitted>
  <study_first_submitted_qc>May 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2010</study_first_posted>
  <last_update_submitted>July 19, 2016</last_update_submitted>
  <last_update_submitted_qc>July 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Singapore Eye Research Institute</investigator_affiliation>
    <investigator_full_name>Jodhbir Mehta</investigator_full_name>
    <investigator_title>Head Tissue Engineering and Stem Cell Group</investigator_title>
  </responsible_party>
  <keyword>Endoglide</keyword>
  <keyword>Endothelial Keratoplasty</keyword>
  <keyword>Donor Insertion</keyword>
  <keyword>DSAEK</keyword>
  <keyword>Corneal Transplant</keyword>
  <keyword>Patients with Bullous Keratopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

